Peter B. Bach, MD
@peterbachmd
Chief Med Officer @DELFIdiagnostic. Pulmonary & ICU doc. Tweets about health policy and grammar. Viewpoints my own.
ID:277191527
http://www.delfidiagnostics.com 04-04-2011 21:50:09
12,0K Tweets
13,8K Followers
1,1K Following
In which Gary Shteyngart proves (again) that his alchemy works on any topic. Extra points for finding a way to write-off the tab at the Lobby Bar.
newyorker.com/culture/annals…
“We cant have the FDA become a Yelp for drugs”. Gregg Gonsalves @gregggonsalves #statsummit
Oh this is going to be a ride. Sloane Crosley riffing on AK in opening graf of Grief is for People.
Today we announced the availability of our fragmentome-based RUO cancer monitoring assay, DELFI-TF, & a new collaboration with Immunocore to explore this assay as an early predictor of benefit from treatment with their ImmTAC-based therapies. Read more: prnewswire.com/news-releases/…
Susan Tousi leaves Illumina to head cancer liquid biopsy startup Delfi.
Jonathan Wosen, Ph.D. talked to her. Read it here. statnews.com/2024/01/04/ill…
Some books I loved in '23 (Stacie Dusetzina Peter Neumann)
- All the beauty in the world (@PBringley)
- Deliver me from nowhere (@WarrenZanes)
- Number go up (@zekefaux)
- Save the cat (@savethecat)
- The guest (by Emma Kline)
- Bird by bird (@annelamott)
TY WH/Dr. Collins for pursuing subscription based model for Hepatitis C elimination (and for the shoutout to our work). Approach fixes a mkt failure and may greatly reduce burden from disease. Here is some history of the approach: drugpricinglab.org/story/how-a-ne…
nytimes.com/2023/11/28/opi…
TY The Cancer Letter. There r two distinct & complimentary liquid bx cancer screening approaches:
- focused for under-screened (but recommended) cancers
- broad for many cancers
Differences in sensitivity imply each saves about the same number of lives. cancerletter.com/guest-editoria…
What a terrific way to start out a Friday. Vanderbilt Health National Cancer Institute
news.vumc.org/2023/11/17/van…